Indoco Remedies Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Indoco Remedies Ltd. on BSE

Load latest

Indoco Remedies Ltd.

22 May 2025

279.35

1.32%

Company Update

Indoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Change in Directorate

BSE India

Re-appointment of Dr. Vasudha Kamat and Mr. Abhijit Gore as an Independent Directors of the Company for second term of five years subject to the approval of the shareholders.

pdf

Indoco Remedies Ltd.

22 May 2025

279.35

1.32%

Result

Indoco Remedies Ltd - 532612 - Financial Results For The Year Ended 31St March, 2025

BSE India

Approval of Standalone and Consolidated Financial Results for the Quarter and Year ended 31st March, 2025

pdf

Indoco Remedies Ltd.

22 May 2025

279.35

1.32%

Board Meeting

Indoco Remedies Ltd - 532612 - Board Meeting Outcome for Financial Results For The Year Ended …

BSE India

Pursuant to the Regulation 30 read with Schedule III and 33 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 ("Listing Regulations"), we hereby inform you that the Board of Directors of the Company at its Meeting held today i.e. 22nd May, 2025 has inter-alia considered and approved the following.1. Audited Financial Results (Consolidated and Standalone) for the quarter and year ended 31st March, 2025 and Auditors' Reports with unmodified opinion on the aforesaid Audited Financial Results.2. Subject to the approval of the Members at the ensuing 78th Annual General Meeting, recommended a Dividend of Rs. 0.20 per equity share on face value of Rs. 2/- for the financial year 2024-2025.

pdf

Indoco Remedies Ltd.

22 May 2025

279.35

1.32%

Annual Report

Annual report for Indoco Remedies Ltd. for FY-2025

None

pdf

Indoco Remedies Ltd.

15 May 2025

279.35

1.32%

Company Update

Indoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Intimation of Earnings Conference Call on Audited Financial Results for the Quarter and Year ended 31st March, 2025

pdf

Indoco Remedies Ltd.

15 May 2025

279.35

1.32%

Company Update

Indoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Intimation of Earnings Conference Call on Audited Financial Results for quarter and Year ended 31st March, 2025

pdf

Indoco Remedies Ltd.

14 May 2025

279.35

1.32%

Board Meeting

Indoco Remedies Ltd - 532612 - Board Meeting Intimation for Audited Results & Dividend

BSE India

Indoco Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2025 ,inter alia, to consider and approve 1. The Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended 31st March, 2025. 2. To recommend a final dividend, if any for the financial year ending 31st March, 2025.

pdf

Indoco Remedies Ltd.

07 Apr 2025

279.35

1.32%

Company Update

Indoco Remedies Ltd - 532612 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Attached the Certificate issued by MUFG Intime India Pvt Ltd, Registrar & Transfer Agent of the Company, confirming compliance under Regulation 74(5) of SEBI (D&P) Regulations,2018 for the quarter ended 31-03-2025.

pdf